| Announce Date | 11/03/2025 |
| EPS Normalized Actual | $-0.00614 (Beat by $0.00386) |
| EPS GAAP Actual | $-0.00614 (Beat by $0.00386) |
| Revenue Actual | $0.100712B |
| Revenue Surprise | Beat by $100.712M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.02 |
| EPS GAAP Estimate | $0.02 |
| Revenue Estimate | $0.1138B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.21 | 3.47 | 0.20011 | 0.21923 | 1 |
| Dec 2028 | 0.14 | 5.21 | 0.13276 | 0.1468 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0045 | -0.007 | 0.100712B | 2.49% | -13.99M |
| FQ2 2025 (Jun 2025) | -0.0673 | -0.060633 | 0.094837B | 6.14% | -21.18M |
| FQ1 2025 (Mar 2025) | -0.04 | -0.003333 | 0.089974B | -9.36% | -15.16M |
| FQ4 2024 (Dec 2024) | -0.0867 | -0.116676 | 0.105877B | -13.01% | -28.46M |
| FQ3 2024 (Sep 2024) | -0.0194 | -0.0194 | 0.098204B | -2.37% | 98.2M |
| FQ1 2020 (Mar 2020) | 0 | 0 | 0.031552B | 100% | 31.55M |
| FQ2 2020 (Jun 2020) | 0 | 0 | 0.031552B | 100% | 31.55M |
| FQ3 2020 (Sep 2020) | 0 | 0 | 0.040899B | 100% | 40.9M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.02
Consensus Revenue Estimates
0.1138B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.02 | -- | 0.01973489 | 0.02026511 | 1 |
| FQ3 2027 (Sep 2027) | 0.01 | -- | 0.00986745 | 0.01013255 | 1 |
| FQ2 2027 (Jun 2027) | -0.01 | -- | -0.01013255 | -0.00986745 | 1 |
| FQ1 2027 (Mar 2027) | -0.01 | -- | -0.01013255 | -0.00986745 | 1 |
| FQ4 2026 (Dec 2026) | 0.01 | -- | 0.00934316 | 0.01094843 | 1 |
| FQ3 2026 (Sep 2026) | 0.01 | 145 | 0.00934316 | 0.01094843 | 1 |
| FQ2 2026 (Jun 2026) | 0.02 | 436.5 | 0.01868632 | 0.02189687 | 1 |
| FQ1 2026 (Mar 2026) | 0.02 | 300 | 0.01868632 | 0.02189687 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.13B | -- | 0.13B | 0.13B | 1 |
| FQ3 2027 (Sep 2027) | 0.12B | -- | 0.12B | 0.12B | 1 |
| FQ2 2027 (Jun 2027) | 0.12B | -- | 0.12B | 0.12B | 1 |
| FQ1 2027 (Mar 2027) | 0.11B | -- | 0.11B | 0.11B | 1 |
| FQ4 2026 (Dec 2026) | 0.15B | -- | 0.15B | 0.16B | 2 |
| FQ3 2026 (Sep 2026) | 0.14B | 27.55 | 0.13B | 0.15B | 2 |
| FQ2 2026 (Jun 2026) | 0.12B | 19.77 | 0.11B | 0.13B | 2 |
| FQ1 2026 (Mar 2026) | 0.11B | 20.94 | 0.11B | 0.12B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
5
EPS # of in-lines
3
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0025 | -0.0045 | -0.007 | 155.56% |
| FQ2 2025 (Jun 2025) | -0.006667 | -0.0673 | -0.060633 | 90.09% |
| FQ1 2025 (Mar 2025) | -0.036667 | -0.04 | -0.003333 | 8.33% |
| FQ4 2024 (Dec 2024) | 0.029976 | -0.0867 | -0.116676 | 134.57% |
| FQ3 2024 (Sep 2024) | -0.0194 | -0.0194 | 100% | |
| FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
| FQ2 2020 (Jun 2020) | 0 | 0 | NAN% | |
| FQ3 2020 (Sep 2020) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.11B | $0.1B | $-13.99M | -13.89% |
| FQ2 2025 (Jun 2025) | $0.12B | $0.09B | $-21.18M | -22.33% |
| FQ1 2025 (Mar 2025) | $0.11B | $0.09B | $-15.16M | -16.85% |
| FQ4 2024 (Dec 2024) | $0.13B | $0.11B | $-28.46M | -26.88% |
| FQ3 2024 (Sep 2024) | $0B | $0.1B | $98.2M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0.03B | $31.55M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.03B | $31.55M | 100% |
| FQ3 2020 (Sep 2020) | $0B | $0.04B | $40.9M | 100% |